Thus, the pleiotropic effects of SGLT2 inhibitors help to modify a host of inflammatory responses in a range of cells and tissues by multiple molecular pathways that improve oxidative stress, cytokine production, immune-system function, and obesity-related inflammation. This evidence concerns the gene SLC5A2 and obesity disorder.